Is caffeine or coffee consumption a risk for new-onset atrial fibrillation? A systematic review and meta-analysis
Eur J Prev Cardiol
.
2021 Oct 13;28(12):e13-e15.
doi: 10.1177/2047487320908385.
Epub 2020 Mar 18.
Authors
Chayakrit Krittanawong
1
,
Anusith Tunhasiriwet
2
,
Zhen Wang
3
4
,
Ann M Farrell
5
,
Sakkarin Chirapongsathorn
2
,
HongJu Zhang
2
,
Takeshi Kitai
6
,
Davendra Mehta
7
Affiliations
1
Section of Cardiology, Baylor College of Medicine, Houston, TX, USA.
2
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, USA.
3
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
4
Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
5
Mayo Clinic Libraries, Mayo Clinic, Rochester, MN, USA.
6
Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Japan.
7
Department of Cardiovascular Diseases, Icahn School of Medicine at Mount Sinai St Luke's, Mount Sinai Heart, USA.
PMID:
34647581
DOI:
10.1177/2047487320908385
No abstract available
Publication types
Letter
Meta-Analysis
Systematic Review
MeSH terms
Atrial Fibrillation* / diagnosis
Atrial Fibrillation* / epidemiology
Caffeine / adverse effects
Coffee* / adverse effects
Humans
Risk Factors
Substances
Coffee
Caffeine